Top

Published in:

01-08-2015 | Research Article

Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro

Authors: Jana Trylcova, Petr Busek, Karel Smetana Jr., Eva Balaziova, Barbora Dvorankova, Alzbeta Mifkova, Aleksi Sedo

Published in: Tumor Biology | Issue 8/2015

Abstract

Cancer-associated fibroblasts (CAFs) significantly influence biological properties of many tumors. The role of these mesenchymal cells is also anticipated in human gliomas. To evaluate the putative role of CAFs in glioblastoma, we tested the effect of CAF conditioned media on the proliferation and chemotaxis of glioma cells. The proliferation of glioma cells was stimulated to similar extent by both the normal fibroblasts (NFs) and CAF-conditioned media. Nevertheless, CAF-conditioned media enhanced the chemotactic migration of glioma cells significantly more potently than the media from normal fibroblasts. In order to determine whether CAF-like cells are present in human glioblastomas, immunofluorescence staining was performed on tissue samples from 20 patients using markers typical for CAFs. This analysis revealed regular presence of mesenchymal cells expressing characteristic CAF markers α-smooth muscle actin and TE-7 in human glioblastomas. These observations indicate the potential role of CAF-like cells in glioblastoma biology.

Polyak K, Haviv I, Campbell IG. Co-evolution of tumor cells and their microenvironment. Trends in genetics. TIG. 2009;25(1):30–8. doi:10.1016/j.tig.2008.10.012.CrossRefPubMed

Cirri P, Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. Am J Cancer Res. 2011;1(4):482–97.PubMedPubMedCentral

Goodpaster T, Legesse-Miller A, Hameed MR, Aisner SC, Randolph-Habecker J, Coller HA. An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem Off J Histochem Soc. 2008;56(4):347–58. doi:10.1369/jhc.7A7287.2007.CrossRef

Smetana K, Dvorankova B, Szabo P, Strnad H, Kolar M. Role of stromal fibroblasts in cancer originated from squamous epithelia. In: Bai X, editor. Dermal fibroblasts: histological perspectives, characterization and role in disease. New York: Nova Sciences Publishers; 2013. p. 83–94.

De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer J Int du Cancer. 2008;123(10):2229–38. doi:10.1002/ijc.23925.CrossRef

Haviv I, Polyak K, Qiu W, Hu M, Campbell I. Origin of carcinoma associated fibroblasts. Cell Cycle. 2009;8(4):589–95.CrossRefPubMed

Strnad H, Lacina L, Kolar M, Cada Z, Vlcek C, Dvorankova B, et al. Head and neck squamous cancer stromal fibroblasts produce growth factors influencing phenotype of normal human keratinocytes. Histochem Cell Biol. 2010;133(2):201–11. doi:10.1007/s00418-009-0661-6.CrossRefPubMed

Kolar M, Szabo P, Dvorankova B, Lacina L, Gabius HJ, Strnad H, et al. Upregulation of IL-6, IL-8 and CXCL-1 production in dermal fibroblasts by normal/malignant epithelial cells in vitro: immunohistochemical and transcriptomic analyses. Biol Cell / Under Auspices Europ Cell Biol Org. 2012;104(12):738–51. doi:10.1111/boc.201200018.

Dvorankova B, Szabo P, Lacina L, Gal P, Uhrova J, Zima T, et al. Human galectins induce conversion of dermal fibroblasts into myofibroblasts and production of extracellular matrix: potential application in tissue engineering and wound repair. Cells Tissues Organs. 2011;194(6):469–80. doi:10.1159/000324864.CrossRefPubMed

10.

Valach J, Fik Z, Strnad H, Chovanec M, Plzak J, Cada Z, et al. Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors. Int J Cancer J Int du Cancer. 2012;131(11):2499–508. doi:10.1002/ijc.27550.CrossRef

11.

Mifkova A, Kodet O, Szabo P, Kucera J, Dvorankova B, Andre S, et al. Synthetic polyamine BPA-C8 inhibits TGF-beta1-mediated conversion of human dermal fibroblast to myofibroblasts and establishment of galectin-1-rich extracellular matrix in vitro. Chembiochem Europ J Chem Biol. 2014;15(10):1465–70. doi:10.1002/cbic.201402087.CrossRef

12.

Dvorankova B, Szabo P, Lacina L, Kodet O, Matouskova E, Smetana Jr K. Fibroblasts prepared from different types of malignant tumors stimulate expression of luminal marker keratin 8 in the EM-G3 breast cancer cell line. Histochem Cell Biol. 2012;137(5):679–85. doi:10.1007/s00418-012-0918-3.CrossRefPubMed

13.

da Fonseca AC, Badie B. Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies. Clinic Dev Immunol. 2013;2013:264124. doi:10.1155/2013/264124.

14.

Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H. The brain tumor microenvironment. Glia. 2012;60(3):502–14.CrossRefPubMed

15.

Clavreul A, Etcheverry A, Chassevent A, Quillien V, Avril T, Jourdan ML, et al. Isolation of a new cell population in the glioblastoma microenvironment. J Neuro-Oncol. 2012;106(3):493–504. doi:10.1007/s11060-011-0701-7.CrossRef

16.

Clavreul A, Guette C, Faguer R, Tetaud C, Boissard A, Lemaire L, et al. Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties. J Pathol. 2014;233(1):74–88. doi:10.1002/path.4332.CrossRefPubMed

17.

Busek P, Stremenova J, Sromova L, Hilser M, Balaziova E, Kosek D, et al. Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity. Int J Biochem Cell Biol. 2012;44(5):738–47. doi:10.1016/j.biocel.2012.01.011.CrossRefPubMed

18.

Haynes BF, Scearce RM, Lobach DF, Hensley LL. Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic microenvironment. J Experiment Med. 1984;159(4):1149–68.CrossRef

19.

Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem. 2007;101(4):805–15. doi:10.1002/jcb.21159.CrossRefPubMed

20.

Filatova A, Acker T, Garvalov BK. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment. Biochim Biophys Acta. 2013;1830(2):2496–508. doi:10.1016/j.bbagen.2012.10.008.CrossRefPubMed

21.

Persano L, Rampazzo E, Basso G, Viola G. Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting. Biochem Pharmacol. 2013;85(5):612–22. doi:10.1016/j.bcp.2012.10.001.CrossRefPubMed

22.

Goritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisen J. A pericyte origin of spinal cord scar tissue. Science. 2011;333(6039):238–42. doi:10.1126/science.1203165.CrossRefPubMed

23.

Wesseling P, Schlingemann RO, Rietveld FJ, Link M, Burger PC, Ruiter DJ. Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study. J Neuropathol Exp Neurol. 1995;54(3):304–10.CrossRefPubMed

24.

Najbauer J, Huszthy PC, Barish ME, Garcia E, Metz MZ, Myers SM, et al. Cellular host responses to gliomas. PLoS One. 2012;7(4):e35150. doi:10.1371/journal.pone.0035150.CrossRefPubMedPubMedCentral

25.

Behnan J, Isakson P, Joel M, Cilio C, Langmoen IA, Vik-Mo EO, et al. Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression. Stem Cells. 2014;32(5):1110–23. doi:10.1002/stem.1614.CrossRefPubMed

26.

Birnbaum T, Hildebrandt J, Nuebling G, Sostak P, Straube A. Glioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro. J Neuro-Oncol. 2011;105(1):57–65. doi:10.1007/s11060-011-0561-1.CrossRef

27.

Cornil I, Theodorescu D, Man S, Herlyn M, Jambrosic J, Kerbel RS. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci U S A. 1991;88(14):6028–32.CrossRefPubMedPubMedCentral

28.

Prowse AB, McQuade LR, Bryant KJ, Marcal H, Gray PP. Identification of potential pluripotency determinants for human embryonic stem cells following proteomic analysis of human and mouse fibroblast conditioned media. J Proteome Res. 2007;6(9):3796–807. doi:10.1021/pr0702262.CrossRefPubMed

29.

Sayegh ET, Kaur G, Bloch O, Parsa AT. Systematic review of protein biomarkers of invasive behavior in glioblastoma. Mol Neurobiol. 2014;49(3):1212–44. doi:10.1007/s12035-013-8593-5.CrossRefPubMed

30.

Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H, et al. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol. 2002;61(7):585–96.CrossRefPubMed

Title: Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro
Authors: Jana Trylcova
Petr Busek
Karel Smetana Jr.
Eva Balaziova
Barbora Dvorankova
Alzbeta Mifkova
Aleksi Sedo
Publication date: 01-08-2015
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 8/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-015-3259-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2015

Association between SNPs in Serpin gene family and risk of esophageal squamous cell carcinoma

Long noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer

The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia

Transcriptome meta-analysis reveals dysregulated pathways in nasopharyngeal carcinoma

The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma

Chemokines and their receptors in esophageal cancer—the systematic review and future perspectives

Keynote webinar | Spotlight on antibody–drug conjugates in cancer